Solithromycin Triskel EU Services (solithromycin)
- Region
- 🇪🇺 EU
- Active substance
- solithromycin
- Company
- Triskel EU Services Ltd
- Status
- Application withdrawn
- Therapeutic area
- Tularemia; Pneumonia; Anthrax
- Application
- EMEA/H/C/004179
- ATC
- J01FA
- Official record
- www.ema.europa.eu
Indication
Treatment of bacterial infections
Regulatory milestones
No milestones recorded in the last year.
Follow Solithromycin Triskel EU Services
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.